Community Blend · Biohacker Stack

Klow Blend

BPC-157 · TB-500 · GHK-Cu · KPV — The four-peptide repair, skin quality and inflammation control stack

Contains

BPC-157 TB-500 GHK-Cu KPV

Component Breakdown

BPC-157

10mg

Tissue repair via nitric oxide and growth factor modulation. Angiogenesis. Gut protection. SubQ or oral.

→ Full entry

TB-500

10mg

Cell migration to injury sites via actin regulation. Accelerates repair cells reaching damaged tissue. SubQ.

→ Full entry

GHK-Cu

50mg

Collagen remodeling, skin quality, gene expression reset. Dominant component at 5:1 ratio. SubQ.

→ Full entry

KPV

10mg

Anti-inflammatory via NF-kB inhibition. Blocks inflammatory cytokine production. SubQ or oral via PepT1 transporter.

→ Full entry

Why These Three Together

Klow takes the three-peptide Glow foundation and adds a fourth layer: dedicated inflammation control. BPC-157 triggers the initial healing response via nitric oxide and growth factor pathways. TB-500 drives cell migration — physically moving repair cells to the damaged site via actin regulation. GHK-Cu remodels what's been repaired — organising collagen, improving skin quality, resetting gene expression. KPV then directly blocks NF-kB, a central inflammation switch, reducing the inflammatory signalling that would otherwise slow all three repair processes. The logic is: clear the inflammatory debris so the builders can work. KPV and BPC-157 can also both be taken orally, making a hybrid oral/injectable version straightforward.

Dosing — Blended Vial (80mg total)

Standard reconstitution: 3mL bacteriostatic water per vial. This gives a concentration of approximately 26.7mg/mL total blend.

Compound	Per Vial	Per 0.1mL Draw	Frequency	Route
GHK-Cu	50mg	~1.67mg	Daily or 5×/wk	SubQ
BPC-157	10mg	~333mcg	Daily or 5×/wk	SubQ or oral
TB-500	10mg	~333mcg	Daily or 5×/wk	SubQ
KPV	10mg	~333mcg	Daily or 5×/wk	SubQ or oral

A 0.10mL draw = ~2.67mg total blend (80mg total per vial). A standard vial at 3mL provides approximately 30 daily doses. Cycle: 8–12 weeks on, 2–4 weeks off. Rotate injection sites — abdomen, thighs, upper arms.

Blend Vial vs Separate Vials

Blend Vial

Single Draw

One reconstitution, one injection per dose. Simpler protocol, fewer vials to manage. Ratio is fixed at 5:1:1 — cannot adjust individual compounds independently. Best for maintenance or straightforward skin/recovery protocols.

Separate Vials

Individual Dosing

Full control over each compound. Can increase TB-500 for acute injury (loading phase), maintain GHK-Cu daily, and cycle BPC-157 separately. More vials, more prep — but better for injury-specific or phase-based protocols.

Reconstitution

Allow vial to reach room temperature before opening. GHK-Cu gives the powder a slight blue tint — this is normal. Draw 3mL bacteriostatic water into a clean syringe.

Insert the needle through the rubber stopper. Inject water slowly down the inside of the vial wall — do not blast directly onto the powder. This prevents degradation of the peptide structure.

Do not shake. Gently swirl or roll the vial until the powder dissolves completely. The solution should be clear with a very faint blue tint from the copper complex.

Store reconstituted vial at 2–8°C (refrigerated). Use within 30 days. Do not freeze the reconstituted solution. Lyophilised (unopened) powder: store at −20°C, stable for 12+ months.

Draw 0.10mL (10 units on a U-100 syringe) for a standard dose. Inject subcutaneously at a 45° angle. Rotate sites each injection. Abdomen, thigh, and upper arm are all suitable.

Evidence Grade per Compound

◆◆◆◇

BPC-157

Strong preclinical (animal). No human RCTs. Extensive community use data.

◆◆◇◇

TB-500

Preclinical data. Veterinary use established. Limited human trials.

◆◆◆◇

GHK-Cu

Strong preclinical + cosmetic trial data. Topical human evidence robust. Injectable human evidence emerging.

◆◆◇◇

KPV

Strong preclinical anti-inflammatory data. Oral bioavailability via PepT1 confirmed. No human RCTs.

◆◇◇◇

Combined

No RCT on the combination specifically. Rationale extrapolated from individual compound data.

Klow vs Glow — When to Choose Each

Klow (this blend) adds KPV to the Glow foundation specifically for situations where inflammation is the limiting factor in recovery. Chronic inflammation, gut involvement, post-surgical healing, or any scenario where the inflammatory environment is actively slowing repair.

Glow (three-peptide) is the simpler maintenance option — same repair and remodelling foundation without the dedicated anti-inflammatory layer. Better when inflammation is not a primary concern. See the Glow entry →

Common Use Cases in the Community

✦

Skin rejuvenation and anti-ageing maintenance — GHK-Cu dominates at 50mg. Collagen remodelling, improved skin density, reduced fine lines. Often run continuously as a low-dose maintenance protocol.

✦

Post-injury recovery — BPC-157 and TB-500 combination widely reported for tendon, ligament, and muscle recovery. GHK-Cu adds extracellular matrix remodelling to the repair.

✦

General tissue maintenance — Used by the biohacker community as a baseline recovery stack alongside training or after periods of high physical stress.

✦

Hair quality — GHK-Cu has preclinical evidence for hair follicle enlargement. Some community members use the blend primarily for scalp and hair quality. Note: WADA prohibits BPC-157 and TB-500 in competitive athletes.

Safety and Considerations

⚠

WADA prohibited — BPC-157 and TB-500 are both prohibited in competitive sport. KPV and GHK-Cu are not currently on the prohibited list. GHK-Cu is not currently on the prohibited list. If you are subject to anti-doping rules, do not use this blend.

⚠

No human RCT on the combination — the rationale for combining these compounds is evidence-based but the synergy is extrapolated from individual compound studies and community experience. This is not a clinically validated protocol.

⚠

Copper accumulation risk with long cycles — GHK-Cu at high doses over extended periods. Standard 8–12 week cycles with rest periods are the community norm. Do not run continuously without breaks.

✓

Generally well tolerated — injection site reactions (transient redness, mild itch) are the most commonly reported side effects across all three components. No serious adverse effects in the published individual compound literature.

Blood Work

No specific blood work is required for the Glow blend that isn't already part of a standard annual panel. If running as part of a broader anti-ageing protocol: inflammatory markers (hsCRP, fibrinogen), liver function, and copper/zinc ratio are worth including at baseline and after 12 weeks. No peptides in this blend are expected to affect hormonal panels.

Educational reference only. For research and informational purposes. Not medical advice. GHK-Cu, BPC-157, and TB-500 are research compounds sold as research use only in the UK. Not for human consumption. Always consult a qualified practitioner before beginning any protocol. © 2026 Pep IQ · pepiq.co.uk